comparemela.com

Latest Breaking News On - Antiviral therapy - Page 4 : comparemela.com

InsightAce Analytic Pvt Ltd : T-cell Lymphoma Market worth $2 89 billion by 2030 - Exclusive Report by InsightAce Analytic

JERSEY CITY, N.J., July 12, 2022 /PRNewswire/ InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global T-cell Lymphoma Market By Lymphoma Type (Peripheral

Insights on the T-cell Lymphoma Global Market to 2028

Worldwide T-cell Lymphoma Industry to 2028 - Featuring Genmab, Seagen and GlaxoSmithKline Among Others

Model shows booster doses and antiviral pills may enable relaxation of SARS-CoV-2 social distancing

Novartis splashes cash on COVID-19 antiviral, plans FDA filing as Molecular Partners links drug to drop in hospitalization, death

Novartis is coming for the COVID-19 antiviral market. After failing in hospitalized patients, Molecular Partners linked ensovibep to a 78% risk reduction in an earlier-stage population, prompting Novartis to pay 150 million Swiss francs ($163 million) for an asset that could soon add to the anti-omicron arsenal. 

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.